Hospital or health organisation · founded 1867
Dayton VA Medical Center
Dayton, United States · dayton.va.gov
- Citations, last 5 years
- 656
- Works, last 5 years
- 161
- h-index
- 97
- Scientists listed
- 0
- Grants since 2016
- 18
Grants received
2025–2029 · grant · I01
Acid Sphingomyelinase Inhibition to Mitigate the Environmental Exposure Risks of Ultraviolet Light-Induced Actinic Neoplasia and Squamous Cell Carcinoma in US Veterans
Craig Rohan · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2021–2026 · grant · I01
Mapping DNA Repair and Error-Prone DNA Synthesis in Geriatric Skin
Michael George Kemp · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2021–2025 · grant · I01
Mapping DNA Repair and Error-Prone DNA Synthesis in Geriatric Skin
Michael George Kemp · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2021–2026 · grant · I01
Mapping DNA Repair and Error-Prone DNA Synthesis in Geriatric Skin
Michael George Kemp · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2021–2026 · grant · I01
Mapping DNA Repair and Error-Prone DNA Synthesis in Geriatric Skin
Michael George Kemp · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2019–2023 · grant · I01
Validation of Mesoscopic Imaging to Predict Cutaneous Carcinogenesis and its Therapeutic Response
Jeffrey B. Travers · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2019–2023 · grant · I01
Validation of Mesoscopic Imaging to Predict Cutaneous Carcinogenesis and its Therapeutic Response
Jeffrey B. Travers · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2019–2023 · grant · I01
Validation of Mesoscopic Imaging to Predict Cutaneous Carcinogenesis and its Therapeutic Response
Jeffrey B. Travers · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2019–2023 · grant · I01
Validation of Mesoscopic Imaging to Predict Cutaneous Carcinogenesis and its Therapeutic Response
Jeffrey B. Travers · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2010–2024 · grant · I01
Oxidized Lipids and UV Immunosuppression
Jeffrey B. Travers · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2010–2024 · grant · I01
Oxidized Lipids and UV Immunosuppression
Jeffrey B. Travers · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2010–2020 · grant · I01
Oxidized lipids and UV immunosuppression
Jeffrey B. Travers · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2010–2024 · grant · I01
Oxidized Lipids and UV Immunosuppression
Jeffrey B. Travers · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2010–2020 · grant · I01
Oxidized lipids and UV immunosuppression
Jeffrey B. Travers · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2010–2020 · grant · I01
Oxidized lipids and UV immunosuppression
Jeffrey B. Travers · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2010–2028 · grant · I01
Oxidized Lipids and UV Immunosuppression
Jeffrey B. Travers · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2010–2020 · grant · I01
Oxidized lipids and UV immunosuppression
Jeffrey B. Travers · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs
2010–2028 · grant · I01
Oxidized Lipids and UV Immunosuppression
Jeffrey B. Travers · Dayton VA Medical Center · funded by U.S. Department of Veterans Affairs